Dr. Martin Andersson, Ph.D. is Head of Biology at Sprint Bioscience AB. He is one of the Founders of the Company. He has been employed at the Company since 2009. He holds a Doctorate in Philosophy degree in Biochemistry from Stockholms universitet. Between 2001 and 2003 he worked to establish a lab for high-throughput protein production and structure determination, pioneering the application of these technologies in a high-throughput format in Europe. In 2003 he joined AstraZeneca working at the AstraZeneca biotech laboratory, a centre of excellence in production of target proteins for use in internal drug discovery projects. He has experience in project management and resource management and during the last years at AstraZeneca Martin worked strategically representing a set of specialized capabilities (Protein science, Structural chemistry and Computational chemistry/compound management) towards customers in one of the research areas within AstraZeneca. Martin is the co-author of 9 peer-reviewed publications.

Protein science, Structural chemistry and Computational chemistry/compound management